|
|
Volumn 256, Issue SUPPL. 1, 2009, Pages 25-30
|
|
Idebenone: An emerging therapy for Friedreich ataxia
|
|
Author keywords
Ataxia rating scale; Clinical trials; Friedreich ataxia; Hypertrophic cardiomyopathy; Idebenone
|
|
Indexed keywords
ADENOSINE TRIPHOSPHATE;
IDEBENONE;
ABSENCE OF SIDE EFFECTS;
AGE DISTRIBUTION;
ALZHEIMER DISEASE;
ANTIOXIDANT ACTIVITY;
BLOOD CELL COUNT;
BODY WEIGHT;
CLINICAL TRIAL;
DIARRHEA;
DRUG DOSE INCREASE;
DRUG MEGADOSE;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSPEPSIA;
ELECTRON TRANSPORT;
FRIEDREICH ATAXIA;
HUMAN;
HYPERTROPHIC CARDIOMYOPATHY;
LIVER FUNCTION;
LOW DRUG DOSE;
MITOCHONDRIAL MEMBRANE;
MITOCHONDRION;
NAUSEA;
NEUROTOXICITY;
NONHUMAN;
OXIDATION REDUCTION REACTION;
PRIORITY JOURNAL;
RECOMMENDED DRUG DOSE;
REVIEW;
SIDE EFFECT;
ANIMALS;
ANTIOXIDANTS;
CARDIOMYOPATHY, HYPERTROPHIC;
FRIEDREICH ATAXIA;
HUMANS;
NERVOUS SYSTEM DISEASES;
UBIQUINONE;
|
|
EID: 62549120780
PISSN: 03405354
EISSN: 14321459
Source Type: Journal
DOI: 10.1007/s00415-009-1005-0 Document Type: Review |
|
Times cited : (72)
|
|
References (22)
|
